Neuromuscular properties of the thigh muscles in patients with ehlers-danlos syndrome

Muscle and Nerve

Volumn 47, Issue 1, 2013, Pages 96-104

  Gerrits, Karin H L ^a   Voermans, Nicol C ^b   de Haan, Arnold ^a   van Engelen, Baziel G ^b  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Electrical stimulation; Joint angle; Muscle strength; Rate of torque development; Tenascin X deficiency

Indexed keywords

TENASCIN; TENASCIN X; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EHLERS DANLOS SYNDROME; FEMALE; HUMAN; ISOMETRICS; KNEE FUNCTION; MALE; MUSCLE; MUSCLE CONTRACTION; MUSCLE LENGTH; PRIORITY JOURNAL; THIGH MUSCLE; TIME; TORQUE;

ADULT; EHLERS-DANLOS SYNDROME; FEMALE; HUMANS; KNEE; KNEE JOINT; MALE; MIDDLE AGED; MOTOR ACTIVITY; MUSCLE CONTRACTION; MUSCLE WEAKNESS; QUADRICEPS MUSCLE; THIGH; TORQUE;

EID: 84871288060     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23482     Document Type: Article

References (28)

1. Beighton P, de Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 1998; 77: 31-37.
2. Burch GH, Gong Y, Liu W, Dettman RW, Curry CJ, Smith L, et al. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat Genet 1997; 17: 104-108.
3. Schalkwijk J, Zweers MC, Steijlen PM, Dean WB, Taylor G, van Vlijmen IM, et al. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N Engl J Med 2001; 345: 1167-1175.
4. Voermans NC, Bonnemann CG, Huijing PA, Hamel BC, van Kuppevelt TH, de Haan A, et al. Clinical and molecular overlap between myopathies and inherited connective tissue diseases. Neuromuscul Disord 2008; 18: 843-856.
5. Beighton P. The Ehlers-Danlos syndromes. London: William Heinemann Medical Books; 1970.
6. Banerjee G, Agarwal RK, Shembesh NM, el Mauhoub M. Ehlers Danlos syndrome-masquerading as primary muscle disease. Postgrad Med J 1988; 64: 126-127.
7. Bilkey WJ, Baxter TL, Kottke FJ, Mundale MO. Muscle formation in Ehlers-Danlos syndrome. Arch Phys Med Rehabil 1981; 62: 444-448.
8. Pretorius ME, Butler IJ. Neurologic manifestations of Ehlers-Danlos syndrome. Neurology 1983; 33: 1087-1089.
9. Yis U, Dirik E, Chambaz C, Steinmann B, Giunta C. Differential diagnosis of muscular hypotonia in infants: the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VI). Neuromuscul Disord 2008; 18: 210-214.
10. Voermans NC, van Alfen N, Pillen S, Lammens M, Schalkwijk J, Zwarts MJ, et al. Neuromuscular involvement in various types of Ehlers-Danlos syndrome. Ann Neurol 2009; 65: 687-697.
11. Huijing PA, Voermans NC, Baan GC, Buse TE, van Engelen BG, de Haan A. Muscle characteristics and altered myofascial force transmission in tenascin-X-deficient mice, a mouse model of Ehlers-Danlos syndrome. J Appl Physiol 2010; 109: 986-995.
12. Voermans NC, Altenburg TM, Hamel BC, de Haan A, van Engelen BG. Reduced quantitative muscle function in tenascin-X deficient Ehlers-Danlos patients. Neuromuscul Disord 2007; 17: 597-602.
13. de Ruiter CJ, Kooistra RD, Paalman MI, de Haan A. Initial phase of maximal voluntary and electrically stimulated knee extension torque development at different knee angles. J Appl Physiol 2004; 97: 1693-1701.
14. van der Ploeg RJ, Fidler V, Oosterhuis HJ. Hand-held myometry: reference values. J Neurol Neurosurg Psychiatry 1991; 54: 244-247.
15. Herzog W, ter Keurs HE. Force-length relation of in-vivo human rectus femoris muscles. Pflugers Arch 1988; 411: 642-647.
16. Gerrits K, Gommans I, van Engelen B, de Haan A. Quadriceps weakness in a family with nemaline myopathy: influence of knee angle. Clin Sci (Lond) 2003; 105: 585-589.
17. Herzog W, Hasler E, Abrahamse SK. A comparison of knee extensor strength curves obtained theoretically and experimentally. Med Sci Sports Exerc 1991; 23: 108-114.
18. de Haan A, de Ruiter CJ, van der Woude LHV, Jongen PJH. Contractile properties and fatigue of quadriceps muscles in multiple sclerosis. Muscle Nerve 2000; 23: 1534-1541.
19. Gerrits KH, Beltman MJ, Koppe PA, Konijnenbelt H, Elich PD, de Haan A, et al. Isometric muscle function of knee extensors and the relation with functional performance in patients with stroke. Arch Phys Med Rehabil 2009; 90: 480-487.
20. Horstman AM, Beltman MJ, Gerrits KH, Koppe P, Janssen TW, Elich P, de Haan A. Intrinsic muscle strength and voluntary activation of both lower limbs and functional performance after stroke. Clin Physiol Funct Imaging 2008; 28: 251-261.
21. Schillings ML, Kalkman JS, Janssen HM, van Engelen BG, Bleijenberg G, Zwarts MJ. Experienced and physiological fatigue in neuromuscular disorders. Clin Neurophysiol 2007; 118: 292-300.
22. Schillings ML, Stegeman DF, Zwarts MJ. Determining central activation failure and peripheral fatigue in the course of sustained maximal voluntary contractions: a model-based approach. J Appl Physiol 2005; 98: 2292-2297.
23. Duchateau J, Hainaut K. Electrical and mechanical changes in immobilized human muscle. J Appl Physiol 1987; 62: 2168-2173.
24. Fatoye F, Palmer S, Macmillan F, Rowe P, van der Linden M. Proprioception and muscle torque deficits in children with hypermobility syndrome. Rheumatology (Oxford) 2009; 48: 152-157.
25. Schillings ML, Kalkman JS, van der Werf SP, van Engelen BG, Bleijenberg G, Zwarts MJ. Diminished central activation during maximal voluntary contraction in chronic fatigue syndrome. Clin Neurophysiol 2004; 115: 2518-2524.
26. Voermans NC, Knoop H, Bleijenberg G, van Engelen BG. Fatigue is associated with muscle weakness in Ehlers-Danlos syndrome: an explorative study. Physiotherapy 2011; 97: 170-174.
27. Thompson RA, Vignos PJ Jr. Serum aldolase in muscle disease. AMA Arch Intern Med 1959; 103: 551-564.
28. Collen FM, Wade DT, Robb GF, Bradshaw CM, Collen FM, Wade DT. The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment Residual mobility problems after stroke. Int Disabil Stud 1991; 13: 50-54.